About Reinventing Drug Discovery

At Regeneron, we move science to medicine because our world is meant for more.

Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

Every day, we apply our homegrown technologies and relentless spirit to help people with serious diseases. See what drives us.

Video of Regeneron employees showing how Regeneron is unique.

From our continued leadership in retinal diseases, to new advances in type 2 allergic conditions, to our emerging immuno-oncology portfolio, see the exciting progress we made last year.

EXPLORE OUR YEAR IN REVIEW DOWNLOAD OUR LATEST RESPONSIBILITY REPORT DOWNLOAD OUR BETTER WORKPLACE. BETTER SCIENCE. BETTER WORLD. IMPACT REPORT

Regeneron by the numbers

35+

years of scientific leadership

13.4K+

employees worldwide

1.5K+

employees with a Ph.D. and/or M.D

consecutive years on the Dow Jones Sustainability World Index

Top 5

ranking in Science magazine's global Top Employer survey for 13 consecutive years

6.7K

volunteers for Day for Doing Good 2023

FDA-approved or authorized medicines

~35

product candidates in clinical development across multiple therapeutic areas

100%

of our waste diverted from landfill, surpassing our 2025 global responsibility goal

~100%

of drug candidates invented and developed in-house

2M+

exomes sequenced to date

231

peer-reviewed publications in 2023

Honors and awards

Dow Jones Sustainability World Index, 2023

Dow Jones Sustainability North American Index, 2023

Human Rights Campaign Foundation: Corporate Equality Index, 2023

Science: Top Employers, 2023

Disability: IN & American Association of People with Disabilities: Best Place to Work for Disability Inclusion, 2023

Fast Company: Best Workplaces for Innovators, 2023

Forbes: America’s Best Employers for Women, 2023

Newsweek: America’s Greenest Companies, 2023

Civic 50: Most Community-Minded Companies in the Nation, 2023

IDEA Pharma: Pharmaceutical Invention Index, 2023

Newsweek: America’s Most Responsible Companies, 2023

Biospace: Best Place to Work, 2023

Glassdoor: Best Places to Work, 2023

Newsweek: America’s Greatest Workplaces for Diversity, 2023

Three Regeneron employees speaking at a panel.

Led by science

We are the only biopharma company founded and led by physician-scientists since the beginning, more than three decades ago. From our first days, science was and remains our central guiding principle. Our leadership includes multiple Nobel Laureates and five members of the National Academy of Sciences, and we are one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard.

Get To Know The Team